Trial NCT05617313

View at ClinicalTrials.gov 
Org. Study IDs: PRO00109146
Secondary IDs: HCRN LUN21-497

Last trial update was posted on 2024-03-04

MeSH Interventions

Pembrolizumab

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Metastatic NSCLC Non Small Cell Lung Cancer Recurrent Non Small Cell Lung Cancer

Stopping Reasons

Interim Analysis

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID